Symbol | Exchange | Currency |
|---|
Acutus Medical jumped in the pre-market after Kerrisdale Capital tweeted that the investment firm “was long AFIB.”Releasing a report on the company titled...
Gainers: [[ASPU]] +6.9%. [[SDC]] +4.9%. [[XM]] +4.5%. [[AFIB]] +4.3%. [[NERV]] +4.0%.
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy | Buy | Sell |
| Technical Indicators | Strong Sell | Neutral | Strong Buy | Sell | Sell |
| Summary | Strong Sell | Neutral | Strong Buy | Neutral | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,660.30 | 2,668.00 | 2,596.00 | +91.9 | +3.58% | 2.08M | NASDAQ | |||
| 369.79 | 375.33 | 357.19 | +18.60 | +5.30% | 33.69M | NASDAQ | |||
| 9.98 | 9.98 | 9.96 | +0.010 | +0.10% | 53.52K | NASDAQ | |||
| 75.94 | 76.04 | 74.89 | +0.41 | +0.54% | 12.35M | NASDAQ | |||
| 3.20 | 3.39 | 3.13 | -0.040 | -1.23% | 14.27K | NASDAQ | |||
| 4.64 | 4.857 | 4.415 | +0.040 | +0.87% | 49.72K | NASDAQ | |||
| 124.62 | 130.73 | 116.16 | -10.06 | -7.47% | 8.68M | NASDAQ | |||
| 36.81 | 36.87 | 36.27 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 7.00 | 7.10 | 6.39 | 0.00 | 0.00% | 13.60K | NASDAQ | |||
| 42.52 | 43.38 | 42.48 | -0.13 | -0.30% | 291.17K | NYSE | |||
| 0.7299 | 0.00 | 0.00 | -0.0801 | -9.89% | 1.73M | NASDAQ | |||
| 195.58 | 197.00 | 192.50 | -0.36 | -0.18% | 19.57M | NASDAQ | |||
| 46.51 | 47.20 | 46.12 | +0.60 | +1.31% | 5.03M | NYSE | |||
| 57.01 | 57.33 | 56.45 | +0.54 | +0.96% | 12.14M | NYSE | |||
| 55.34 | 56.28 | 54.73 | -0.90 | -1.60% | 10.62M | NYSE |
Acutus Medical, Inc. is an arrhythmia management company. The Company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. The Company’s product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Its AcQMap System consists of the single-use AcQMap catheter as well as its console, workstation and software algorithms. With 48 ultrasound transducers interspersed between 48 biopotential electrodes, its mapping catheter collects the data required to create a map of the cardiac anatomy and electrical propagation pathways and patterns. The Company’s software algorithms analyze the biopotential data and maps any type of arrhythmia, including atrial fibrillation, as well as all supraventricular tachycardias and ventricular arrhythmias.
